Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12534557 | 0.89 | S1PR2 (0.39) | — | |
| SCHEMBL12534540 | 0.85 | ALDH1A1 (0.34) | TSHR | |
| SCHEMBL12723947 | 0.81 | SAT1 (0.36) | — | |
| SCHEMBL12534539 | 0.80 | ALDH1A1 (0.36) | TSHR | |
| SCHEMBL12534559 | 0.79 | LPAR3 (0.42) | — | |
| SCHEMBL12534530 | 0.75 | TSHR (0.39) | TSHR | |
| SCHEMBL12534555 | 0.74 | BTN3A1 (0.32) | — | |
| SCHEMBL12723949 | 0.72 | — | — | |
| SCHEMBL12534563 | 0.72 | APP (0.31) | — | |
| SCHEMBL17350333 | 0.71 | ALDH1A1 (0.34) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7932303-B2 | Materials based on radically polymerizable N,O-functionalized acrylic acid hydroxamides | IVOCLAR VIVADENT AG (LI) | 2011-04-26 | — | — | US | disclosed |
| US-20080234405-A1 | very quickly cured; particularly suitable for dental purposes | IVOCLAR VIVADENT AG (LI) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234405-A1 | very quickly cured; particularly suitable for dental purposes | HRH4, HRH2, HRH3 | GABBR2 738/4885CYP1A2 808/4885TSHR 3656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.